Any thoughts on the prospects of its upcoming Zoptrex phase 3 data Dew? http://www.businesswire.com/news/home/20160606006290/en/Aeterna-Zentaris-Reconfirms-Commitment-LHRH-receptor-Targeting-Zoptrex%E2%84%A2 AEZS had been on my watch list. Glad I didn't get in. Considering getting a small speculative position for Zoptrex though.